Skip to content
Search

Latest Stories

Pharmacist-led study warns against substandard hand sanitisers

Consumers face a ‘real risk’ of purchasing hand cleaners with low or inadequate concentrations of alcohol, a new study has warned.

The researchers, who looked at the effectiveness of hand sanitisers in the fight against COVID-19, added that such products “cannot ensure disinfection and are not fit for use”.


“Much more worrying is the presence of hand cleaners on the market containing low (“substandard”) and/or unknown concentrations of alcohol that are not commercialised as disinfectants,” the study, published in the International Journal of Pharmaceutics, states.

“There is a tangible risk that consumers might, and are using, hand cleaners, which product appearance is very similar to hand disinfectants, while being unaware that such products cannot ensure disinfection and are not fit for use amid the CoViD-19 pandemic.”

The study suggests pharmacists and retailers to advise customers over the selection of appropriate products to minimise the risk. The authors also call for awareness campaigns among the public and a review of current rules on hand sanitisers by the regulators.

The research, a collaboration between eight pharmacists based at universities in the UK, Italy and Jordan, analysed hand sanitisers available on the Italian market. It also proposes detailed “recipes” for the manufacture of effective hand sanitising gels.

The researchers also believe that the current demand for the hand sanitisers is likely to remain high for long.

“Public awareness on the importance of hand sanitisation during this pandemic is likely to have long term effects on hygiene habits across the world. The public is likely to endure the routine use of hand sanitisers, even beyond the CoViD-19 era, as a new norm of self-hygiene,” the article reads.

The University of Huddersfield has been the participating institution from the UK in the study.

More For You

Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less
Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less